TAKE LIMITED
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from TAKE LIMITED's yearly results (2023–2026), compared with Healthcare companies in India. Tap ? on any ratio for what it means.
What stands out
- Tangible Net Worth Ratio: Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies. More tangible than 98% of Healthcare companies in India.
- Tangible Assets Ratio: Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles. More tangible than 98% of Healthcare companies in India.
- Steadiness Ratio: Sales grew in 1 of the last 3 years; profit grew in 1 of 3. Less steady than 94% of Healthcare companies in India.
Where ₹100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
−₹2Money owed to suppliers is larger than money owed by customers plus stock: ₹2 per ₹100 of sales comes from others' credit, against ₹2 from others' credit three years earlier.
Less money tied up than 89% of Healthcare companies in India.
Growth quality
Steadiness Ratio
1/3 · 1/3Sales grew in 1 of the last 3 years; profit grew in 1 of 3.
Less steady than 94% of Healthcare companies in India.
Growth Efficiency Ratio
—Sales fell 71%
Sales fell 71% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-71% / -84%In 3 years sales changed by -71% while total assets changed by -84%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
No debt dueNo debt falls due within a year, according to the latest yearly balance sheet.
Cash Cushion Ratio
+11%Cash, after subtracting all debt, equals 11% of its market value (net cash).
Higher than 91% of Healthcare companies in India.
Tangible Assets Ratio
100%Of every ₹100 the company owns, ₹100 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 98% of Healthcare companies in India.
Tangible Net Worth Ratio
100%Of every ₹100 of net worth, ₹100 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
More tangible than 98% of Healthcare companies in India.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (13)
TAKE LIMITED owes ₹0.14 for every ₹1 it owns. Net profit fell 71% in the year to Mar 2026.
Compared with Healthcare companies in India · latest annual results Mar 2026.
P/E ratio
29.5Investors pay ₹29.5 for every ₹1 of TAKE LIMITED's yearly profit, lower than 65% of Healthcare companies in India.
P/B ratio
5.42The share price is 5.42 times TAKE LIMITED's book value per share, higher than 59% of Healthcare companies in India.
Market cap
₹168 CrThe total market value of all of TAKE LIMITED's shares at today's price (share price × number of shares), smaller than 93% of Healthcare companies in India. PosiCap size class: Micro Cap.
Net worth (book value)
₹31 CrWhat TAKE LIMITED would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (31 Mar 2026).
Book value per share
₹2.12Net worth divided by the number of shares. The share price of ₹11.50 is 5.4 times this, which is the P/B above.
Return on equity (ROE)
18.9%TAKE LIMITED earned 18.9% on its shareholders' money over the last year, higher than 77% of Healthcare companies in India.
Owes vs Owns
0.14×TAKE LIMITED owes ₹0.14 for every ₹1 it owns (low), lower than 93% of Healthcare companies in India.
Dividend yield
NoneTAKE LIMITED does not currently pay a dividend.
Profit growth
-71%Net profit fell 71% in the year to Mar 2026.
Profit margin
20.0%TAKE LIMITED keeps ₹20 of every ₹100 of revenue as net profit.
Cash quality
-0.4×Cash from TAKE LIMITED's business was -0.4× its reported profit in the year to Mar 2026 — the business used cash even though it reported a profit.
Interest cover
Not coveredTAKE LIMITED's operating profit did not cover its interest costs in the year to Mar 2026.
Cash vs debt
Net cashTAKE LIMITED held ₹18 Cr more cash than debt (net cash) at Mar 2026.
Questions
What is TAKE LIMITED's P/E ratio?
Investors pay ₹29.5 for every ₹1 of TAKE LIMITED's yearly profit, lower than 65% of Healthcare companies in India.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For TAKE LIMITED: ₹168 Cr ÷ ₹31 Cr (31 Mar 2026) = 5.4.
What is TAKE LIMITED's return on equity?
TAKE LIMITED earned 18.9% on its shareholders' money over the last year, higher than 77% of Healthcare companies in India.
How much does TAKE LIMITED owe compared with what it owns?
TAKE LIMITED owes ₹0.14 for every ₹1 it owns (low), lower than 93% of Healthcare companies in India.
Does TAKE LIMITED pay a dividend?
No. TAKE LIMITED does not currently pay a dividend.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.